Somnomed
TX - PlanoBiotechnology
Focus: Somnomed is a Texas-based medical device company founded in 2004 specializing in mandibular repositioning appliances for obstructive sleep apnea treatment. The company operates in the biotechnology/device segment with a focused product portfolio.
Profile data last refreshed 9h ago · AI intelligence enriched 1w ago
Open Jobs
7+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at Somnomed?
AI assessmentBest suited for professionals seeking stability in a niche medical device market rather than high-growth biotech trajectory or robust pipeline visibility.
Why Work Here
- Established company with 20-year operating history in a high-prevalence disease area (obstructive sleep apnea affects millions globally)
- Focused pipeline with active clinical trial activity demonstrates ongoing R&D commitment
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
mandibular repositioning appliance
Sleep Apnea, ObstructiveClinical Trials (1)
NCT01588275MRA Therapy Versus CPAP Therapy in Moderate OSAS
N/AHelp build intelligence for Somnomed
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.